Home > Product Storage and Stability Information > Rare Endocrine Disorders
Rare Endocrine Disorders
Explore other therapeutic areas
After initial use, all Norditropin® FlexPro® prefilled pens can EITHER be stored at room temperature up to 77°F/25°C for use within 3 weeks, OR in the refrigerator (36°F - 46°F/2°C - 8°C) for use within 4 weeks. It is preferable to choose one storage option and any unused portion must be discarded.1
Recommended Storage Conditions for Norditropin®1
Before First Use
After First Use
Refrigerated (36°F - 46°F)
Room temperature (up to 77°F)
Refrigerated (36°F - 46°F)
Until expiration date
3 weeks
4 weeks
Before and during use, Sogroya® can be stored in the refrigerator (36°F to 46°F/2°C to 8°C) with the cap on in the original carton to protect the product from light.2 Discard the prefilled pen if kept above 86°F (30°C).
Unopened Sogroya® can be stored in the refrigerator (36°F to 46°F/2°C to 8°C) until the expiration date on the carton or at room temperature up to 77°F (25°C) for a maximum of 72 hours (3 days).2 Opened Sogroya® is stable for up to 6 weeks in refrigerated conditions (36°F to 46°F/2°C to 8°C) or at room temperature up to 77°F (25°C) for a maximum of 72 hours (3 days).
The total allowed time at room temperature (up to 77°F/25°C) is 72 hours (3 days) and includes time spent at room temperature both opened and unopened.2 The time spent at room temperature while unopened should be subtracted from the total 72 hours (3 days) allowed at room temperature to determine how long Sogroya® can be at room temperature during the 6-week in-use period.
Recommended Storage Conditions for Sogroya®2
Before First Use
After First Use
Refrigerated (36°F - 46°F)
Room temperature (up to 77°F)
Refrigerated (36°F - 46°F)
Until expiration date
72 hours
6 weeks
References
- Norditropin® Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
- Sogroya® Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
Find more information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
